Oral Tranexamic Acid in Hip and Knee Arthroplasty: A Prospective Cohort Study


Intravenous Tranexamic acid has been shown to decrease blood transfusion requirements in sur- gery. Little evidence exists regarding the much cheaper oral form. The objective of this cohort study was to evaluate whether oral tranexamic acid administration in patients undergoing elec- tive hip and knee replacement surgery resulted in decreased transfusion requirements. Methods: We assessed the transfusion requirements of 332 patients following unilateral total hip or knee arthroplasty, with the first 140 receiving no tranexamic acid and the next 192 given 1 g oral tranexamic acid one hour prior to and a further 1 g 4 hours post joint arthroplasty. Haemoglobin before and after surgery, the number of units transfused post-operatively and the incidence of deep vein thrombosis or pulmonary embolism were recorded. Results: In the first group, there were 22 instances of transfusion (15.7%) and a mean haemoglobin drop of 32.2 g/L, while the second (tranexamic acid) group had just 12 patients transfused (6.3%) and a mean haemoglobin drop of 24.6 g/L (both significantly less, p < 0.01). There was no significant difference in deep vein thrombosis or pulmonary embolism rates between groups. Conclusions: This is the first prospective study to analyze the outcome of oral tranexamic acid administration in hip and knee replacement. We conclude that oral tranexamic acid administration is a safe and effective means to decrease transfusion requirements in joint arthroplasty and is a much cheaper alternative to intravenous preparations of tranexamic acid.

Share and Cite:

McGrath, S. , Yates, P. and Prosser, G. (2014) Oral Tranexamic Acid in Hip and Knee Arthroplasty: A Prospective Cohort Study. Open Journal of Orthopedics, 4, 215-220. doi: 10.4236/ojo.2014.48035.

Conflicts of Interest

The authors declare no conflicts of interest.


[1] Isbister, J.P., Shander, A., Spahn, D.R., Erhard, J., Farmer, S.L. and Hofmann, A. (2011) Adverse Blood Transfusion Outcomes: Establishing Causation. Transfusion Medicine Reviews, 25, 89-101.
[2] Spahn, D.R. and Goodnough, L.T. (2013) Alternatives to Blood Transfusion. Lancet, 381, 1855-1865.
[3] Hofmann, A., Farmer, S.L. and Shander, A. (2011) Five Drivers Shifting the Paradigm from Product-Focused Transfusion Practice to Patient Blood Management. Oncologist, 16, 3-11.
[4] Henry, D.A., Carless, P.A., Moxey, A.J., O’Connell, D., Stokes, B.J., Fergusson, D.A. and Ker, K. (2011) Anti-Fibrinolytic Use for Minimising Perioperative Allogeneic Blood Transfusion. Cochrane Database of Systematic Reviews, Article ID: CD001886.
[5] Collaborators C-2T (2010) Effects of Tranexamic Acid on Death, Vascular Occlusive Events, and Blood Transfusion in Trauma Patients with Significant Haemorrhage (CRASH-2): A Randomised, Placebo-Controlled Trial. Lancet, 376, 23-32.
[6] Sukeik, M., Alshryda, S., Haddad, F.S. and Mason, J.M. (2011) Systematic Review and Meta-Analysis of the Use of Tranexamic Acid in Total Hip Replacement. Journal of Bone and Joint Surgery (British Volume), 93, 39-46.
[7] Orpen, N.M., Little, C., Walker, G. and Crawfurd, E.J.P. (2006) Tranexamic Acid Reduces Early Post-Operative Blood Loss after Total Knee Arthroplasty: A Prospective Randomised Controlled Trial of 29 Patients. Knee, 13, 106-110.
[8] Zhou, X.-D., Tao, L.-J., Li, J. and Wu, L.-D. (2013) Do We Really Need Tranexamic Acid in Total Hip Arthroplasty? A Meta-Analysis of Nineteen Randomized Controlled Trials. Archives of Orthopaedic and Trauma Surgery, 133, 1017-1027.
[9] Phillips, S.J., Chavan, R., Porter, M.L., Kay, P.R., Hodgkinson, J.P., Purbach, B., et al. (2006) Does Salvage and Tranexamic Acid Reduce the Need for Blood Transfusion in Revision Hip Surgery? Journal of Bone and Joint Surgery (British Volume), 88, 1141-1142.
[10] Charoencholvanich, K. and Siriwattanasakul, P. (2011) Tranexamic Acid Reduces Blood Loss and Blood Transfusion after TKA: A Prospective Randomized Controlled Trial. Clinical Orthopaedics and Related Research, 469, 2874-2880.
[11] Lin, P.-C., Hsu, C.-H., Huang, C.-C., Chen, W.-S. and Wang, J.-W. (2012) The Blood-Saving Effect of Tranexamic Acid in Minimally Invasive Total Knee Replacement: Is an Additional Pre-Operative Injection Effective? Journal of Bone and Joint Surgery (British Volume), 94, 932-936.
[12] Imai, N., Dohmae, Y., Suda, K., Miyasaka, D., Ito, T. and Endo, N. (2012) Tranexamic Acid for Reduction of Blood Loss during Total Hip Arthroplasty. The Journal of Arthroplasty, 27, 1838-1843.
[13] Maniar, R.N., Kumar, G., Singhi, T., Nayak, R.M. and Maniar, P.R. (2012) Most Effective Regimen of Tranexamic Acid in Knee Arthroplasty: A Prospective Randomized Controlled Study in 240 Patients. Clinical Orthopaedics and Related Research, 470, 2605-2612.
[14] Ker, K., Edwards, P., Perel, P., Shakur, H. and Roberts, I. (2012) Effect of Tranexamic Acid on Surgical Bleeding: Systematic Review and Cumulative Meta-Analysis. BMJ, 344, e3054.
[15] Alshryda, S., Sarda, P., Sukeik, M., Nargol, A., Blenkinsopp, J. and Mason, J.M. (2011) Tranexamic Acid in Total Knee Replacement: A Systematic Review and Meta-Analysis. Journal of Bone and Joint Surgery (British Volume), 93, 1577-1585.
[16] Zohar, E., Ellis, M., Ifrach, N., Stern, A., Sapir, O. and Fredman, B. (2004) The Postoperative Blood-Sparing Efficacy of Oral versus Intravenous Tranexamic Acid after Total Knee Replacement. Anesthesia Analgesia, 99, 1679-1683.
[17] Irwin, A., Khan, S.K., Jameson, S.S., Tate, R.C., Copeland, C. and Reed, M.R. (2013) Oral versus Intravenous Tranexamic Acid in Enhanced-Recovery Primary Total Hip and Knee Replacement: Results of 3000 Procedures. Journal of Bone and Joint Surgery (British Volume), 95, 1556-1561. http://dx.doi.org/10.1302/0301-620X.95B11.31055
[18] Ho, K.M. and Ismail, H. (2003) Use of Intravenous Tranexamic Acid to Reduce Allogeneic Blood Transfusion in Total Hip and Knee Arthroplasty: A Meta-Analysis. Anaesthesia and Intensive Care Journal, 31, 529-537.
[19] Gillette, B.P., DeSimone, L.J., Trousdale, R.T., Pagnano, M.W. and Sierra, R.J. (2012) Low Risk of Thromboembolic Complications with Tranexamic Acid after Primary Total Hip and Knee Arthroplasty. Clinical Orthopaedics and Related Research, 471, 150-154.
[20] Yang, Z.-G., Chen, W.-P. and Wu, L.-D. (2012) Effectiveness and Safety of Tranexamic Acid in Reducing Blood Loss in Total Knee Arthroplasty: A Meta-Analysis. The Journal of Bone and Joint Surgery (American Volume), 94, 1153-1159.
[21] Farmer, S.L., Towler, S.C., Leahy, M.F. and Hofmann, A. (2013) Drivers for Change: Western Australia Patient Blood Management Program (WA PBMP), World Health Assembly (WHA) and Advisory Committee on Blood Safety and Availability (ACBSA). Best Practice Research Clinical Anaesthesiology, 27, 43-58.
[22] Mukhtar, S.A., Leahy, M.F., Trentino, K., Koay, A., Semmens, J.B., Tovey, J., Jewlachow, J., et al. (2013) Effectiveness of a Patient Blood Management Data System in Monitoring Blood Use in Western Australia. Anaesthesia and Intensive Care, 41, 207-215.
[23] Leahy, M.F. and Mukhtar, S.A. (2012) From Blood Transfusion to Patient Blood Management: A New Paradigm for Patient Care and Cost Assessment of Blood Transfusion Practice. Internal Medicine, 42, 332-338.

Copyright © 2022 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.